NAD refers Bremmen Clinical diet-aid ad claims to FTC
NEW YORK — The National Advertising Division on Tuesday referred advertising claims made by Bremmen Clinical, for its Vysera-CLS weight-loss supplement, to the Federal Trade Commission for further review.
NAD had requested substantiation for certain claims made by Bremmen Clinical for Vysera, including: “As incredible as it sounds, groundbreaking research has just identified a compound that can not only help you lose weight, but can actually reshape your entire body, reducing waist size, hip size, thigh and buttock circumference and … last but not least … cause a significant loss of actual fat mass from all over your body. Has the ‘miracle pill’ finally arrived?”
However, during the course of its review, NAD learned Bremmen Clinical is associated with Basic Research, a company that has entered into a 20-year consent order with the FTC regarding advertising weight-loss claims for several of its dietary supplements.
NAD procedures provide that NAD may administratively close a proceeding, as it did in this case, when the claims at issues are the subject of federal agency consent decree or order.
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
First Aid Shot Therapy launches analgesic shot in Seattle market
SEATTLE — First Aid Shot Therapy on Wednesday announced the launch of its F.A.S.T. Pain Relief product, a berry-flavored, single-dose, liquid relief shot. According to the company, F.A.S.T.’s active ingredient choline salicylate may enter a person’s blood stream up to five times faster than aspirin.
F.A.S.T. Pain Relief temporarily relieves headache, muscle pain, toothache, menstrual pain, pain and fever of colds, minor pain of arthritis and temporarily reduces fever. The active ingredients in the single-dose, pre-measured 1.35-fl. oz. (40 ml) liquid relief shot are choline salicylate (KOE-leen sa-LIS-i-late) and caffeine.
"We started F.A.S.T. because we wanted people to be able to take charge of their health in a better way than they’ve been able to do anytime in the past 50 years," Mary Page Platerink, CEO First Aid Shot Therapy said. "Americans have grown accustomed to taking a pill to manage their pain, but the growth of the energy shot market showed us that the time was right to bring together fast-acting liquid medicines in a single-dose bottle so people could better manage their own health in a more convenient way."
And, while F.A.S.T. Pain Relief has just made its debut, the company’s second liquid relief product, F.A.S.T. Upset Stomach Relief, will be introduced in early 2014.
"Getting sick never comes at the right time; it’s usually while you’re at the office or driving in your car, not when you’re standing in front of your medicine cabinet," Platerink added. "We wanted to create a product that was a quick, simple, no-mess, convenient, single-dose of relief that gives people control over their health and that’s exactly what we did."
F.A.S.T. products can be purchased in the greater Seattle area at retailers including Bartell Drugs, Haggen/Top Foods and online at Amazon.com.
Survey: Patients have hard time tolerating iron supplements
NORTH ANDOVER, Mass. — According to new research commissioned by Nelson, of the most commonly recommended vitamins and minerals, patients have the hardest time tolerating iron.
Researchers from Market Dynamics surveyed 300 U.S. healthcare professionals including physicians, pharmacists, nurse practitioners and dieticians/nutritionists to learn more about their patient conversations around vitamin and mineral supplements. Among the findings — iron led the way in patient complaints.
One-in-two healthcare professionals (48%) indicated that patients "regularly" complained about the side effects from iron. These professionals heard iron complaints at roughly double the rate they did for seven other common supplements, including calcium (28%), vitamin D (27%) and potassium (20%).
Most healthcare professionals (87%) agreed that consumers have a problem taking OTC iron supplements. Nearly 1-in-4 healthcare professionals indicated that at least half their patients who should be taking iron supplements aren’t due to the side effects.
Overall, healthcare providers were mostly likely to speak with pregnant women (47%), seniors (45%), vegetarians (38%) and menopausal women (35%) about iron deficiencies and supplements.
Nelsons manufactures Spatone pur-Absorb Iron, an iron supplement with a clinically proven absorption rate of more than 40%. Because pur-Absorb is more readily absorbed by the body, it can be taken in lower dosages, causing fewer reports of side effects among patients, Nelsons noted.
The Vitamin and Mineral Supplement Survey was fielded between June 11 and July 11.